WO1999040771A3 - Concurrent flow mixing for preparing compositions comprising gene therapy vectors - Google Patents

Concurrent flow mixing for preparing compositions comprising gene therapy vectors Download PDF

Info

Publication number
WO1999040771A3
WO1999040771A3 PCT/US1999/003226 US9903226W WO9940771A3 WO 1999040771 A3 WO1999040771 A3 WO 1999040771A3 US 9903226 W US9903226 W US 9903226W WO 9940771 A3 WO9940771 A3 WO 9940771A3
Authority
WO
WIPO (PCT)
Prior art keywords
gene therapy
compositions
therapy vectors
flow mixing
preparing compositions
Prior art date
Application number
PCT/US1999/003226
Other languages
French (fr)
Other versions
WO1999040771A2 (en
Inventor
Xian Chen
Andrea Mark J D
Original Assignee
Selective Genetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Selective Genetics Inc filed Critical Selective Genetics Inc
Priority to EP99909489A priority Critical patent/EP1054694A2/en
Priority to AU28680/99A priority patent/AU2868099A/en
Publication of WO1999040771A2 publication Critical patent/WO1999040771A2/en
Publication of WO1999040771A3 publication Critical patent/WO1999040771A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/645—Polycationic or polyanionic oligopeptides, polypeptides or polyamino acids, e.g. polylysine, polyarginine, polyglutamic acid or peptide TAT

Abstract

The invention relates generally to methods and apparatuses that are adapted for the preparation of gene therapeutic compositions, as well as the compositions formed thereby. The invention also relates to methods adapted for making mixtures and condensate compositions. In the various embodiments, the present invention provides controlled and uniform mixing of gene therapy vectors and gene therapy vector vehicles for improved reproducibility, scaleability, stability, and pharmaceutical efficacy. Such compositions are suitable for use in mediation of disease.
PCT/US1999/003226 1998-02-13 1999-02-16 Concurrent flow mixing for preparing compositions comprising gene therapy vectors WO1999040771A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP99909489A EP1054694A2 (en) 1998-02-13 1999-02-16 Concurrent flow mixing methods and apparatuses for the preparation of gene therapy vectors and compositions prepared thereby
AU28680/99A AU2868099A (en) 1998-02-13 1999-02-16 Concurrent flow mixing methods and apparatuses for the preparation of gene therapy vectors and compositions prepared thereby

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2335498A 1998-02-13 1998-02-13
US09/023,354 1998-02-13

Publications (2)

Publication Number Publication Date
WO1999040771A2 WO1999040771A2 (en) 1999-08-19
WO1999040771A3 true WO1999040771A3 (en) 1999-11-25

Family

ID=21814604

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1999/003226 WO1999040771A2 (en) 1998-02-13 1999-02-16 Concurrent flow mixing for preparing compositions comprising gene therapy vectors

Country Status (4)

Country Link
US (1) US6537813B1 (en)
EP (1) EP1054694A2 (en)
AU (1) AU2868099A (en)
WO (1) WO1999040771A2 (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001520889A (en) 1997-10-24 2001-11-06 バレンティス，インコーポレイティド Methods for preparing polynucleotide transfection complexes
ATE324913T1 (en) 1998-08-14 2006-06-15 Valentis Inc CO-LYOPHILIZED COMPLEX COMPRISING A NUCLEIC ACID VECTOR AND A FORMULATION AGENT
US20040059416A1 (en) * 1999-06-22 2004-03-25 Murray Martha M. Biologic replacement for fibrin clot
US6964685B2 (en) 1999-06-22 2005-11-15 The Brigham And Women's Hospital, Inc. Biologic replacement for fibrin clot
US20050037086A1 (en) * 1999-11-19 2005-02-17 Zycos Inc., A Delaware Corporation Continuous-flow method for preparing microparticles
PT1295611E (en) * 2000-06-20 2010-09-14 Dainippon Sumitomo Pharma Co Oligonucleotide-transferring preparations
KR100888566B1 (en) * 2001-06-20 2009-03-12 다이닛본 스미토모 세이야꾸 가부시끼가이샤 Method of promoting nucleic acid transfer
KR20040104579A (en) * 2002-04-24 2004-12-10 가부시키가이샤 바이오 메디아 Method of measuring formaldehyde concentration of gas and measuring instrument
EP1581201A4 (en) * 2002-12-23 2011-03-30 Vical Inc Method for producing sterile polynucleotide based medicaments
JP4954550B2 (en) * 2003-12-19 2012-06-20 大日本住友製薬株式会社 Novel nucleic acid introduction method
WO2005089926A1 (en) * 2004-03-23 2005-09-29 Kyowa Hakko Kogyo Co., Ltd. Method for producing coated fine particles
US7638477B2 (en) * 2005-03-09 2009-12-29 Alberto-Culver Company Sustained-release fragrance delivery system
US20090062184A1 (en) * 2005-03-24 2009-03-05 Dainippon Sumitomo Pharma Co., Ltd. Fine particulate preparation comprising complex of nucleic acid molecule and collagen
US20090306776A1 (en) 2006-01-25 2009-12-10 Children's Medical Center Corporation Methods and procedures for ligament repair
NZ571965A (en) * 2006-03-30 2012-02-24 Engene Inc Chitosan-based nanoparticles and methods for transfecting gut cells in vivo
JP2010509943A (en) 2006-09-28 2010-04-02 チルドレンズ メディカル センター コーポレーション Method of repairing tissue and collagen product therefor
DE102007015136A1 (en) * 2007-03-29 2008-10-02 Boehringer Ingelheim Pharma Gmbh & Co. Kg Shear stress application
WO2009039657A1 (en) * 2007-09-28 2009-04-02 Engene, Inc. High concentration chitosan-nucleic acid polyplex compositions
RU2013145080A (en) 2011-03-09 2015-04-20 Пикселл Медикал Текнолоджиз Лтд. DISPOSABLE CARTRIDGE FOR PREPARING A Sample OF A FLUID CONTAINING A CELL FOR ANALYSIS
WO2013116744A1 (en) 2012-02-01 2013-08-08 Children's Medical Center Corporation Biomaterial for articular cartilage maintenance and treatment of arthritis
EP3798226A1 (en) 2013-02-01 2021-03-31 Children's Medical Center Corporation Collagen scaffolds
WO2018041921A1 (en) 2016-08-31 2018-03-08 Curevac Ag Mixing device for the production of a liquid nucleic acid composition
AU2021404929A1 (en) * 2020-12-21 2023-07-06 Pfizer Inc. Methods and systems for improved cell transfection

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5116315A (en) * 1989-10-03 1992-05-26 Hemaedics, Inc. Biological syringe system
US5354844A (en) * 1989-03-16 1994-10-11 Boehringer Ingelheim International Gmbh Protein-polycation conjugates
US5505704A (en) * 1993-04-02 1996-04-09 Eli Lilly And Company Manifold medication injection apparatus and method
WO1996012006A2 (en) * 1994-10-12 1996-04-25 Genetronics, Inc. Flow through electroporation apparatus and method
US5595897A (en) * 1994-04-28 1997-01-21 I.D.M. Immuno-Designed Molecules Polylysine conjugates

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1429184A (en) 1972-04-20 1976-03-24 Allen & Hanburys Ltd Physically anti-inflammatory steroids for use in aerosols
US4044126A (en) 1972-04-20 1977-08-23 Allen & Hanburys Limited Steroidal aerosol compositions and process for the preparation thereof
US3828980A (en) 1972-11-06 1974-08-13 Chem Dev Corp Dispenser for precisely metered dispensing of viscous fluids
US3956044A (en) 1974-05-15 1976-05-11 Surgicot, Inc. Method and means for fabricating surgical sponges
US4045238A (en) 1974-05-20 1977-08-30 Avicon, Inc. Regenerated cellulose sponge
US4222671A (en) 1978-09-05 1980-09-16 Gilmore Oscar Patrick Static mixer
US4534659A (en) 1984-01-27 1985-08-13 Millipore Corporation Passive fluid mixing system
US4897355A (en) * 1985-01-07 1990-01-30 Syntex (U.S.A.) Inc. N[ω,(ω-1)-dialkyloxy]- and N-[ω,(ω-1)-dialkenyloxy]-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor
US4647212A (en) 1986-03-11 1987-03-03 Act Laboratories, Inc. Continuous, static mixing apparatus
US4908187A (en) 1987-04-01 1990-03-13 Endowment For Research In Human Biology, Inc. Device for diluting and mixing liquids and applications for kinetic analysis
DE3782044T2 (en) 1987-04-10 1993-03-25 Chugoku Kayaku MIXER.
US5166320A (en) 1987-04-22 1992-11-24 University Of Connecticut Carrier system and method for the introduction of genes into mammalian cells
USRE34487E (en) 1987-05-20 1993-12-28 Keller Wilhelm A Dispensing apparatus for operating double cartridges
US4978336A (en) 1987-09-29 1990-12-18 Hemaedics, Inc. Biological syringe system
US5277914A (en) * 1989-03-31 1994-01-11 The Regents Of The University Of California Preparation of liposome and lipid complex compositions
US5116868A (en) 1989-05-03 1992-05-26 The Johns Hopkins University Effective ophthalmic irrigation solution
US4979942A (en) 1989-10-16 1990-12-25 Johnson & Johnson Medical, Inc. Two component syringe delivery system
US5218088A (en) 1989-11-02 1993-06-08 Purdue Research Foundation Process for preparing dithiophosphate oligonucleotide analogs via nucleoside thiophosphoramidite intermediates
US5088499A (en) * 1989-12-22 1992-02-18 Unger Evan C Liposomes as contrast agents for ultrasonic imaging and methods for preparing the same
US5534328A (en) 1993-12-02 1996-07-09 E. I. Du Pont De Nemours And Company Integrated chemical processing apparatus and processes for the preparation thereof
KR100327521B1 (en) 1993-03-19 2002-07-03 이.아이,듀우판드네모아앤드캄파니 Integrated chemical processing device and its manufacturing method
DE59406065D1 (en) * 1993-03-24 1998-07-02 Ciba Geigy Ag Process for the production of a liposome dispersion in the high pressure range
USD351466S (en) 1993-04-02 1994-10-11 Eli Lilly And Company Medication injector
USD351465S (en) 1993-04-02 1994-10-11 Eli Lilly And Company Medication injector
IL128775A (en) * 1994-03-07 2001-05-20 Dow Chemical Co Composition comprising a dendritic polymer in complex with at least one unit of biological response modifier and a process for the preparation thereof
ES2316148T3 (en) 1994-03-23 2009-04-01 Ohio University COMPACTED NUCLEIC ACIDS AND ITS SUPPLY TO CELLS.
US5580523A (en) 1994-04-01 1996-12-03 Bard; Allen J. Integrated chemical synthesizers
US5595712A (en) 1994-07-25 1997-01-21 E. I. Du Pont De Nemours And Company Chemical mixing and reaction apparatus
US5527928A (en) * 1994-09-30 1996-06-18 Nantz; Michael H. Cationic transport reagents
US5766899A (en) * 1995-02-27 1998-06-16 Board Of Regents , The University Of Texas System Targeted nucleic acid delivery into liver cells
JPH11505805A (en) 1995-05-16 1999-05-25 プリズム ファーマシューティカルズ，インコーポレイテッド Compositions containing nucleic acids and ligands for therapeutic treatment
AU6011496A (en) 1995-06-08 1997-01-09 Therexsys Limited Improved pharmaceutical compositions for gene therapy
US5658537A (en) 1995-07-18 1997-08-19 Basf Corporation Plate-type chemical reactor
USD380827S (en) 1995-12-13 1997-07-08 Eli Lilly And Company Multi-cartridge medication injector

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5354844A (en) * 1989-03-16 1994-10-11 Boehringer Ingelheim International Gmbh Protein-polycation conjugates
US5116315A (en) * 1989-10-03 1992-05-26 Hemaedics, Inc. Biological syringe system
US5505704A (en) * 1993-04-02 1996-04-09 Eli Lilly And Company Manifold medication injection apparatus and method
US5595897A (en) * 1994-04-28 1997-01-21 I.D.M. Immuno-Designed Molecules Polylysine conjugates
WO1996012006A2 (en) * 1994-10-12 1996-04-25 Genetronics, Inc. Flow through electroporation apparatus and method

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DAVIS, LAWRENCE C. ET AL: "A simple, reliable rapid-mixing apparatus for continuous-flow studies", ANAL. BIOCHEM. (1979), 97(2), 428-37, XP002114959 *

Also Published As

Publication number Publication date
AU2868099A (en) 1999-08-30
EP1054694A2 (en) 2000-11-29
US6537813B1 (en) 2003-03-25
WO1999040771A2 (en) 1999-08-19

Similar Documents

Publication Publication Date Title
WO1999040771A3 (en) Concurrent flow mixing for preparing compositions comprising gene therapy vectors
WO2002002624A3 (en) B7-like molecules and uses thereof
WO1999014346A3 (en) SENSE mRNA THERAPY
WO2002024891A3 (en) B7-like molecules and uses thereof
WO2001070977A3 (en) Fibroblast growth factor receptor-like molecules and uses thereof
WO1998055495A3 (en) Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof
ID27788A (en) TUMOR ANTIGENAL PEPTIDES OBTAINED FROM CYCLEFILIN B
WO2001072962A3 (en) Novel prostate-specific or testis-specific nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
WO2003000707A3 (en) Antisense modulation of superoxide dismutase 1, soluble expression
DE60225586D1 (en)
CA2345354A1 (en) Antisense modulation of bcl-x expression
WO2001092308A3 (en) Cystine-knot polypeptides: cloaked-2 molecules and uses thereof
WO2001061007A3 (en) Fibroblast growth factor-23 molecules and uses thereof
EP0797999A3 (en) Formulations of obesity protein
WO2001068854A3 (en) Fibroblast growth factor-like molecules and uses thereof
WO2001083774A3 (en) Novel mutated form of arginine deiminase
WO1999064594A8 (en) Genes and gene expression products that are differentially regulated in prostate cancer
WO2003022222A3 (en) Antisense modulation of protein kinase r expression
WO2001068705A3 (en) Il-17 receptor like molecules and uses thereof
WO2001079164A3 (en) N-substituted dithiocarbamates for the treatment of biological disorders
WO2003054154A3 (en) Antisense modulation of mucin 1, transmembrane expression
CA2265444A1 (en) Tnf-beta-like protein for treating prostate cancer, and related nucleic acid molecules, pharmaceutical compositions and methods
WO2001042474A3 (en) Interferon-like molecules and uses thereof
WO2002062954A3 (en) Antisense modulation of casein kinase 2-beta expression
MXPA03000979A (en) C3b/C4b COMPLEMENT RECEPTOR-LIKE MOLECULES AND USES THEREOF.

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM HR HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM HR HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

NENP Non-entry into the national phase

Ref country code: KR

WWE Wipo information: entry into national phase

Ref document number: 1999909489

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1999909489

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 1999909489

Country of ref document: EP